The goals and objectives of the Society are:
​
To promote basic and translational research leading to the development of fetal therapies
To raise public and scientific awareness of the need for development of fetal treatments
To develop and maintain an international registry of treated patients and their outcomes to facilitate reporting and sharing of results. This database will not be publicly accessible and data should be anonymized.
To promote the establishment of mutually beneficial collaborations among its members
Our mission
​
To accelerate clinical applications of stem cell transplantation and gene therapy approaches, to treat fetuses with congenital disorders.
​
​
​
Our vision
​
Eliminate disease before it starts
​
​
Current President
​
Graça Almeida-Porada, MD, PhD
Wake Forest Institute for Regenerative Medicine
​
President Elect 2025
​
​
Past President(s)
​
Anna David, PhD
UCL Institute for Women's Health​
​
Secretary
​
Citra Mattar, MD
National University of Singapore
​
Treasurer
​
William H. Peranteau, MD
Children's Institute for Surgical Science at the Children's Hospital of Philadelphia
​
Board of Directors
​
Graça Almeida-Porada, MD, PhD
Wake Forest Institute for Regenerative Medicine
​
Karin Blakemore
Prenatal Genetics, Prenatal Diagnostic Center
John Hopkins Medicine
​
​
Paolo De Coppi, MD, PhD
UCL Institute of Child Health in London
​
Alan W. Flake, MD, FACS, FAAP
Children's Institute for Surgical Science at the Children's Hospital of Philadelphia
​
Cecilia Götherström, PhD
Karolinska University Hospital
​
Tippi Mackenzie, MD
University of California San Francisco ​
​
Christopher Porada, PhD
Wake Forest Institute for Regenerative Medicine
​
Magnus Westgren, MD, PhD
Karolinska University Hospital
​
​
​​​​
Founding Presidents
​
Tippi Mackenzie, MD
University of California, San Francisco
Division of Pediatric Surgery and the Fetal Treatment Center
​
Graça Almeida-Porada, MD, PhD
Wake Forest Institute for Regenerative Medicine
Fetal Research and Therapy Center
​
​
​